Shin Nippon Biomedical Laboratories, Ltd.
Simbols: 2395.T
JPX
1392
JPYTirgus cena šodien
10.3343
P/E koeficients
-0.0844
PEG koeficients
57.95B
MRK Cap
- 0.04%
DIV ienesīgums
Shin Nippon Biomedical Laboratories, Ltd. (2395-T) Finanšu pārskati
Bilance
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 10533.1 | 6997 | 7286.5 | |||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | -423.6 | 368.1 | 55.8 | |||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 4760.4 | 3501.6 | 2954.1 | |||||||||||||||||||
balance-sheet.row.inventory | 0 | 7329.4 | 4359.4 | 4071.4 | |||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 1276.7 | 1276.5 | 468.1 | |||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 23899.6 | 16134.5 | 14780 | |||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 18879.3 | 13155.8 | 12898 | |||||||||||||||||||
balance-sheet.row.goodwill | 0 | 1438.8 | 0.3 | 0.8 | |||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 260.7 | 212 | 213 | |||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1699.4 | 212.3 | 213.8 | |||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 12404 | 8645 | 8522 | |||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 325.8 | 1129.6 | 521.6 | |||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 34.2 | 35.4 | 37 | |||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 33342.6 | 23178.2 | 22192.4 | |||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.total-assets | 0 | 57242.2 | 39312.7 | 36972.4 | |||||||||||||||||||
balance-sheet.row.account-payables | 0 | 419.8 | 64.6 | 95 | |||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 8923.2 | 2942.7 | 3486.8 | |||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 603.7 | 743.1 | 683.2 | |||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 9837.5 | 6195.6 | 9199.2 | |||||||||||||||||||
Deferred Revenue Non Current | 0 | -1064 | -68.2 | -642.4 | |||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 3009.8 | 2685.1 | 2317.4 | |||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 9871.5 | 6215.6 | 9217.8 | |||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 357 | 385.8 | 529.3 | |||||||||||||||||||
balance-sheet.row.total-liab | 0 | 30883.2 | 19589.5 | 21133.6 | |||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 2620.8 | 105.7 | |||||||||||||||||||
balance-sheet.row.common-stock | 0 | 9679.1 | 9679.1 | 9679.1 | |||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 13766.2 | 10196.3 | 3854.5 | |||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 460.2 | -2620.8 | -105.7 | |||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 2306.4 | -314.3 | 2200.9 | |||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 26211.8 | 19561.1 | 15734.5 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 57242.2 | 39312.7 | 36972.4 | |||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 147.2 | 162 | 104.3 | |||||||||||||||||||
balance-sheet.row.total-equity | 0 | 26359 | 19723.1 | 15838.8 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||
Total Investments | 0 | 11980.4 | 7080.1 | 8286.9 | |||||||||||||||||||
balance-sheet.row.total-debt | 0 | 18760.7 | 9138.3 | 12686.1 | |||||||||||||||||||
balance-sheet.row.net-debt | 0 | 8227.6 | 2509.4 | 5455.3 |
Naudas plūsmas pārskats
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 7759.6 | 8183.3 | 4175.6 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 1600.5 | 1177.4 | 1187.7 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -2812.9 | 723.3 | 532 | |||||||||||||||||||
cash-flows.row.account-receivables | 0 | -937 | -480 | -343 | |||||||||||||||||||
cash-flows.row.inventory | 0 | -968.5 | -371.1 | -71.7 | |||||||||||||||||||
cash-flows.row.account-payables | 0 | -268.2 | -36.7 | -24.2 | |||||||||||||||||||
cash-flows.row.other-working-capital | 0 | -639.2 | 1611.1 | 970.8 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -2543.2 | -4131.3 | -1148.5 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -4955.7 | -1614.3 | -1118 | |||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | -1937.2 | 1200.8 | 1242.3 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -1514.3 | -4194.1 | -895 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 2532.2 | 266.7 | 91.4 | |||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | -55.5 | 72.3 | 410.6 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -5930.6 | -4268.5 | -268.7 | |||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -5468.1 | -3492.3 | -4598.2 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0.2 | 0 | 0 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -0.2 | 0 | 0 | |||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -2484.4 | -826.5 | -206.2 | |||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 14218.8 | -593.1 | 2333.4 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 6266.2 | -4912 | -2471.1 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 311.5 | 496.7 | 29.6 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 4648.9 | -2731 | 2036.6 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 9197.7 | 4548.8 | 7279.8 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 4548.8 | 7279.8 | 5243.3 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 4004 | 5952.8 | 4746.7 | |||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -4955.7 | -1614.3 | -1118 | |||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -951.7 | 4338.5 | 3628.7 |
Peļņas vai zaudējumu aprēķina rinda
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 25090.9 | 17748.5 | 15110.5 | |||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 12044.2 | 8061.2 | 7556.1 | |||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 13046.7 | 9687.3 | 7554.4 | |||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 15.2 | 191.1 | 211.4 | |||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 7801.4 | 5491.7 | 5024.9 | |||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 19845.7 | 13552.9 | 12581 | |||||||||||||||||||
income-statement-row.row.interest-income | 0 | 57.4 | 8.3 | 3 | |||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 125.1 | 126.6 | 184.9 | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 2514 | 3986 | 1644 | |||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 15.2 | 191.1 | 211.4 | |||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 2514 | 3986 | 1644 | |||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 125.1 | 126.6 | 184.9 | |||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1600.5 | 1177.4 | 1187.7 | |||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.operating-income | 0 | 5245.2 | 4195.6 | 2529.5 | |||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 7759.6 | 8183.3 | 4175.6 | |||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 1708.9 | 1016.2 | 497.8 | |||||||||||||||||||
income-statement-row.row.net-income | 0 | 6060.1 | 7127.6 | 3661.9 |
Biežāk uzdotie jautājumi
Kas ir Shin Nippon Biomedical Laboratories, Ltd. (2395.T) kopējie aktīvi?
Shin Nippon Biomedical Laboratories, Ltd. (2395.T) kopējie aktīvi ir 57242205000.000.
Kādi ir uzņēmuma gada ieņēmumi?
Gada ieņēmumi ir N/A.
Kāda ir uzņēmuma peļņas norma?
Uzņēmuma peļņas norma ir 0.522.
Kāda ir uzņēmuma brīvā naudas plūsma?
Brīvā naudas plūsma ir 85.787.
Kāda ir uzņēmuma neto peļņas norma?
Neto peļņas norma ir 0.206.
Kādi ir uzņēmuma kopējie ieņēmumi?
Kopējie ieņēmumi ir 0.150.
Kāda ir Shin Nippon Biomedical Laboratories, Ltd. (2395.T) tīrā peļņa (tīrie ienākumi)?
Tīrā peļņa (tīrie ienākumi) ir 6060057000.000.
Kāds ir uzņēmuma kopējais parāds?
Kopējais parāds ir 18760662000.000.
Kāds ir pamatdarbības izdevumu skaits?
Darbības izdevumi ir 7801426000.000.
Kāds ir uzņēmuma skaidrās naudas rādītājs?
Uzņēmuma nauda ir 0.000.